free from anti-depressant drug treatment, and was largely restricted to those who died by violent means. Rapid progress is being made in understanding the There are no differences in 5-HT 1D binding in putamen, regulation of NOS activity and the cellular and molecuparietal or frontal cortex and no differences in 5-lar targets of NO under physiologic and pathologic con-HT 1E/1F binding in any of the regions studied. ditions. NO may play a role not only in physiologic neuronal functions such as neurotransmitter release, neural development, regeneration, synaptic plasticity Chronic haloperidol treatment differentially affects and regulation of gene expression but also in a variety the expression of synaptic and neuronal plasticityof neurological disorders in which excessive proassociated genes duction of NO leads to neural injury. Uncovering the SL Eastwood, J Heffernan, PJ Harrison molecular events in these phenomena as well as other Repeated administration of antipsychotic drugs proproposed roles of NO in neural development, repair, duces a variety of neurochemical and ultrastructural and behavior will hopefully lead to the discovery of effects in some brain regions. In this study, the authors therapeutic stragegies for pathologic neuronal funcexamined the effects of 2 weeks' haloperidol treatment tions caused by malfunction of the NO system. in the rat. They looked at synaptophysin mRNA, a presynaptic terminal protein which is used to demonstrate synaptic alterations in pathological and experimental IMMEDIATE COMMUNICATION conditions. The authors noted an increased expression Confirmation of association between attention deficit of synaptophysin mRNA in some brain regions such as hyperactivity disorder and a dopamine transporter the striatum and the frontoparietal cortex but not in the polymorphism hippocampus. They interpreted those data as evidence M Gill, G Daly, S Heron, Z Hawi, M Fitzgerald of an increased density or reorganization of synaptic populations in certain brain regions which may be Attention deficit hyperactivity is a common disorder of childhood which has a strong genetic component and caused by chronic antipsychotic drug treatment. This finding will contribute to the accumulation of inforwhich responds to treatment with stimulant drugs which inhibit the dopamine transporter (DAT1). The mation on antipsychotic drugs and may prove useful in the assessment of the effects of long-term treatment authors examined the frequency of alleles of a repeat polymorphism in the 3′ untranslated region of the for psychiatric disorders. 
Leptin levels in patients with anorexia nervosa are

